BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Hoeck J, Braeckmans K, De Smedt SC, Raemdonck K. Non-viral siRNA delivery to T cells: Challenges and opportunities in cancer immunotherapy. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tong L, Liu D, Cao Z, Zheng N, Mao C, Liu S, He L, Liu S. Research Status and Prospect of Non-Viral Vectors Based on siRNA: A Review. Int J Mol Sci 2023;24. [PMID: 36834783 DOI: 10.3390/ijms24043375] [Reference Citation Analysis]
2 Ning L, Jia Y, Zhao X, Tang R, Wang F, You C. Nanocellulose-based drug carriers: Functional design, controllable synthesis, and therapeutic applications. Int J Biol Macromol 2022:S0141-8130(22)02207-3. [PMID: 36195234 DOI: 10.1016/j.ijbiomac.2022.09.266] [Reference Citation Analysis]
3 Yang M, Olaoba OT, Zhang C, Kimchi ET, Staveley-o’carroll KF, Li G. Cancer Immunotherapy and Delivery System: An Update. Pharmaceutics 2022;14:1630. [DOI: 10.3390/pharmaceutics14081630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]